Last reviewed · How we verify
NCT04691037: CICM-SCP
CCTA Improves Clinical Management of Stable Chest Pain
trial testing CCTA in Coronary Computed Tomography Angiography in 50,000 participants. Currently enrolling.
1 January 2030
Quick facts
| Lead sponsor | Tianjin Chest Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 50,000 |
| Start date | 1 January 2016 |
| Primary completion | 1 January 2030 |
| Estimated completion | 1 January 2030 |
| Sites | 4 locations across China |
Drugs / interventions tested
- CCTA
Conditions studied
- Coronary Computed Tomography Angiography — all drugs for Coronary Computed Tomography Angiography →
- Stable Chest Pain — all drugs for Stable Chest Pain →
- Optimal Medical Therapy — all drugs for Optimal Medical Therapy →
- Invasive Coronary Angiography — all drugs for Invasive Coronary Angiography →
Sponsor
Tianjin Chest Hospital
Who can join
18 and older, any sex, with Coronary Computed Tomography Angiography or Stable Chest Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigator aims to prospectively enroll patients who were referred for coronary computed tomography angiography (CCTA) for the assessment of stable chest pain (SCP) suspected of obstructive coronary artery disease (CAD). All patients underwent CCTA according to established guidelines and local institutional protocols. The imaging data were evaluated using different image post-processing software to comprehensively analyse anatomical, functional and histological information of coronary. This study will determine if CCTA-based imaging evaluation can provide more informaton to improve clinical management for SCP, including fewer MACE and better decision-making of downstream investigations and therapeutic interventions.
Publications & conference data
7 peer-reviewed publications reference this trial (live from Europe PMC):
-
Association between Coronary Artery Disease Reporting and Data System-recommended Post-Coronary CT Angiography Management and Clinical Outcomes in Patients with Stable Chest Pain from a Chinese Registry.
Zhou J, Li C, Zhang H, Liu C, et al · · 2023 · cited 8× · PMID 37310243 · DOI 10.1148/radiol.222965 -
Identification of vulnerable non-culprit lesions by coronary computed tomography angiography in patients with chronic coronary syndrome and diabetes mellitus.
Zhao J, Zhang H, Liu C, Zhang Y, et al · · 2023 · cited 3× · PMID 37034343 · DOI 10.3389/fcvm.2023.1143119 -
Validation and Comparison of PROMISE and CONFIRM Model to Predict High-Risk Coronary Artery Disease in Symptomatic and Diabetes Mellitus Patients.
Jiang H, Feng J, Feng C, Ren P, et al · · 2022 · cited 3× · PMID 35345247 · DOI 10.31083/j.rcm2303080 -
Coronary Artery Calcium Score Improves Risk Assessment of Symptomatic Patients in Low-Risk Group Based on Current Guidelines.
Wang C, Zhang X, Liu C, Zhang C, et al · · 2023 · cited 1× · PMID 39077531 · DOI 10.31083/j.rcm2406162 -
Comparison of the RF-CL and CACS-CL models to estimate the pretest probability of obstructive coronary artery disease and predict prognosis in patients with stable chest pain and diabetes mellitus.
Chen T, Shao D, Zhao J, Xiu M, et al · · 2024 · cited 1× · PMID 38586168 · DOI 10.3389/fcvm.2024.1368743 -
Comparison of coronary artery calcium score-based and all-coronary computed tomography angiography strategies in patients with stable chest pain and risk factor-weighted clinical likelihood of 5-15.
Wang P, Chen T, He M, Xin T, et al · · 2026 · PMID 41721263 · DOI 10.1186/s12880-026-02232-3 -
Coronary Artery Calcium Score-Weighted Clinical Likelihood Model Performance in Patients with Stable Chest Pain and Coronary Artery Calcium Scores of Zero.
Tan Y, Liu C, Chen T, Li Y, et al · · 2024 · PMID 39076944 · DOI 10.31083/j.rcm2503085
Verify or expand the search:
- PubMed search for NCT04691037
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CCTA
Trials testing the same drug.
- NCT06552663 — The Diagnostic Power Of Coronary CT Angiography In Patients With Chest Pain And Zero Calcium Score · not yet recruiting
- NCT06101862 — Coronary Computed Tomography Versus Invasive Angiography for Non-ST Elevation Acute Coronary Syndrome · NA · recruiting
- NCT06956924 — Abdominal Aortic Calcium and CAD-RADS 2.0 · NA · completed
- NCT04424121 — CCTA, CACS and ECG Stress Testing in Patients With Suspected CAD: Precision Phenotyping and Financial Evaluation · NA · unknown
- NCT03689946 — Effect of Evolocumab on Coronary Atherosclerosis · Phase 3 · completed
Other recruiting trials for Coronary Computed Tomography Angiography
Currently open trials in the same condition.
- NCT06603363 — Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT · NA · recruiting
- NCT06670768 — Myocardial Perfusion Quantification With SPECT Using Multi-Pinhole Collimator Compared to Photon-Counting Coronary CTA · NA · recruiting
- NCT06879769 — Optimization of Patient Preparation and Imaging Techniques for Cardiac CT · NA · recruiting
Other Tianjin Chest Hospital trials
Trials by the same sponsor.
- NCT07063147 — TTE Improves Clinical Management of Stable Chest Pain · recruiting
- NCT05640752 — Optimal Evaluation to Reduce Cardiovascular Imaging Testing · NA · recruiting
- NCT05578222 — Pembrolizumab as First-line Treatment for Advanced NSCLC Complicated With COPD · Phase 2 · unknown
- NCT04100434 — Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in P · Phase 4 · unknown
- NCT03600259 — Tianjin Inpatient Acute Myocardial Infarction Registry · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04691037 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tianjin Chest Hospital
- Last refreshed: 28 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04691037.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing